Rankings
▼
Calendar
ARGX Q2 2024 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$902M
+92.6% YoY
Gross Profit
$1.3B
142.1% margin
Operating Income
-$139M
-15.4% margin
Net Income
-$33M
-3.6% margin
EPS (Diluted)
$-0.55
QoQ Revenue Growth
+124.9%
Cash Flow
Operating Cash Flow
-$125M
Free Cash Flow
-$125M
Stock-Based Comp.
$103M
Balance Sheet
Total Assets
$4.8B
Total Liabilities
$534M
Stockholders' Equity
$4.3B
Cash & Equivalents
$1.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$902M
$468M
+92.6%
Gross Profit
$1.3B
$107M
+1095.6%
Operating Income
-$139M
-$189M
+26.4%
Net Income
-$33M
-$113M
+71.2%
← FY 2024
All Quarters
Q3 2024 →